Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial

To date, no antiviral therapy has shown proven clinical effectiveness in treating patients with COVID-19. We assessed the efficacy of remdesivir in hospitalized Egyptian patients with COVID-19. Patients were randomly assigned at a 1:1 ratio to receive either remdesivir (200 mg on the first day follo...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd-Elsalam, Sherief, Salama, Marwa, Soliman, Shaimaa, Naguib, Ahmed Mohamed, Ibrahim, Ibrahim S., Torky, Mohamed, El Ghafar, Mohamed Samir Abd, Abdul-Baki, Enas Abdul-Raouf M., Elhendawy, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922517/
https://www.ncbi.nlm.nih.gov/pubmed/34649223
http://dx.doi.org/10.4269/ajtmh.21-0606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922517/
https://www.ncbi.nlm.nih.gov/pubmed/34649223
http://dx.doi.org/10.4269/ajtmh.21-0606

Ejemplares similares